VYM vs XLV
Holdings Overlap Analysis
VYM and XLV are largely complementary, with only 13.8% weighted overlap. Pairing them is an effective way to diversify across different segments of the market.
What each fund holds
VYM holds about 600 US companies with above-average dividend yields from the FTSE High Dividend Yield index, giving broad, cap-weighted exposure to higher-yielding large caps at 0.06%.
Tracks the FTSE High Dividend Yield · Full replication · 1940 Act
Full profile of VYMXLV holds the roughly 60 health care companies in the S&P 500, led by Eli Lilly, Johnson & Johnson and AbbVie, in the Select Sector SPDR for health care.
Tracks the Health Care Select Sector · Full replication · 1940 Act
Full profile of XLVAnalysis
By weight, about 13.8% of VYM and XLV is identical, across 20 common holdings. That gives a diversification score of 86/100 — the two are largely complementary.
Their top 10 positions account for 26% of VYM and 60% of XLV, making XLV the more concentrated of the two. The widest sector gap is Health Care, where XLV is overweight by roughly 85.8 percentage points.
Adding XLV on top of VYM introduces 43 holdings you don't already own — names like Eli Lilly & (LLY), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG).
Side-by-side
| VYM | XLV | |
|---|---|---|
| Name | Vanguard High Dividend Yield ETF | Health Care Select Sector SPDR Fund |
| Issuer | Vanguard | State Street |
| Tracks | FTSE High Dividend Yield | Health Care Select Sector |
| Structure | 1940 Act, US | 1940 Act, US |
| AUM | $60.0B | $38.0B |
| Expense ratio | 0.06% | 0.09% |
| Holdings | 593 | 63 |
| Holdings as of | Nov 9, 2026 | Nov 9, 2026 |
Top Shared Holdings
| # | Ticker | Name | Weight A | Weight B | Sector |
|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 2.71% | 9.79% | Health Care |
| 2 | ABBV | AbbVie Inc. | 1.97% | 7.59% | Health Care |
| 3 | MRK | Merck & Co. Inc. | 1.53% | 5.41% | Health Care |
| 4 | UNH | UnitedHealth Group Inc. | 1.41% | 5.30% | Health Care |
| 5 | AMGN | Amgen Inc. | 0.89% | 3.71% | Health Care |
| 6 | GILD | Gilead Sciences Inc. | 0.79% | 3.10% | Health Care |
| 7 | ABT | Abbott Laboratories | 0.73% | 2.93% | Health Care |
| 8 | PFE | Pfizer Inc. | 0.69% | 2.50% | Health Care |
| 9 | BMY | Bristol-Myers Squibb Co | 0.54% | 1.92% | Health Care |
| 10 | MDT | Medtronic plc | 0.47% | 1.91% | Health Care |
| 11 | CVS | CVS Health Corp. | 0.47% | 1.55% | Health Care |
| 12 | ELV | Anthem Inc. | 0.35% | 1.40% | Health Care |
| 13 | CI | Cigna Group/The | 0.30% | 1.19% | Health Care |
| 14 | CAH | Cardinal Health Inc. | 0.22% | 0.93% | Health Care |
| 15 | BDX | Becton Dickinson and Co. | 0.21% | 0.87% | Health Care |
| 16 | HUM | Humana Inc. | 0.19% | 0.74% | Health Care |
| 17 | ZTS | Zoetis Inc. | 0.12% | 0.51% | Health Care |
| 18 | DGX | Quest Diagnostics Inc. | 0.11% | 0.42% | Health Care |
| 19 | VTRS | Viatris Inc | 0.09% | 0.32% | Health Care |
| 20 | BAX | Baxter International Inc | 0.05% | 0.20% | Health Care |
| — |
Biggest Weight Differences
Stocks both funds hold, but at very different weights — where the two ETFs tilt apart.
| Holding | VYM | XLV | Diff |
|---|---|---|---|
| JNJ Johnson & Johnson | 2.71% | 9.79% | -7.08 |
| ABBV AbbVie Inc. | 1.97% | 7.59% | -5.62 |
| UNH UnitedHealth Group Inc. | 1.41% | 5.30% | -3.89 |
| MRK Merck & Co. Inc. | 1.53% | 5.41% | -3.88 |
| AMGN Amgen Inc. | 0.89% | 3.71% | -2.82 |
| GILD Gilead Sciences Inc. | 0.79% | 3.10% | -2.31 |
| ABT Abbott Laboratories | 0.73% | 2.93% | -2.20 |
| PFE Pfizer Inc. | 0.69% | 2.50% | -1.81 |
| MDT Medtronic plc | 0.47% | 1.91% | -1.44 |
| BMY Bristol-Myers Squibb Co | 0.54% | 1.92% | -1.38 |
Unique Holdings
Stocks held by only one of the two funds — the exposure you gain (or lose) by switching.
Only in VYM 573 holdings
Only in XLV 43 holdings
Concentration & Sector Tilt
How top-heavy each fund is, and which sectors each one leans into. Sector weights are our own roll-up of the GICS sector on each holding in the issuer's holdings file, so they can differ slightly from the issuer's factsheet.
Top 10 is measured against the full fund, not rescaled to the equity sleeve, and each share class (for example Alphabet A and C) counts as a separate holding. Issuer factsheets that combine share classes and exclude cash and currency forwards from the denominator can show a figure about a point higher.
| Sector | Overweight | By |
|---|---|---|
| Health Care | XLV | +85.8 pts |
| Financials | VYM | +21.1 pts |
| Information Technology | VYM | +16.3 pts |
| Industrials | VYM | +12.4 pts |
| Energy | VYM | +10.1 pts |
| Consumer Staples | VYM | +8.2 pts |
| Consumer Discretionary | VYM | +5.7 pts |
| Utilities | VYM | +5.1 pts |
Sector Overlap
FAQ
Share & Embed
Writing about VYM vs XLV? You're welcome to use this chart or the live widget in your article — just link back to this page as the source.
Interactive widget that always shows current overlap data:
Static chart image (works on Substack, Medium, forums):
Live preview: